Vectofusin-1 Improves Transduction of Primary Human Cells with Diverse Retroviral and Lentiviral Pseudotypes, Enabling Robust, Automated Closed-System Manufacturing

Cell and gene therapies are finally becoming viable patient treatment options, with both T cell- and hematopoietic stem cell (HSC)-based therapies being approved to market in Europe. However, these therapies, which involve the use of viral vector to modify the target cells, are expensive and there i...

詳細記述

保存先:
書誌詳細
出版年:Hum Gene Ther
主要な著者: Radek, Constanze, Bernadin, Ornellie, Drechsel, Katharina, Cordes, Nicole, Pfeifer, Rita, Sträßer, Pia, Mormin, Mirella, Gutierrez-Guerrero, Alejandra, Cosset, François-loïc, Kaiser, Andrew D., Schaser, Thomas, Galy, Anne, Verhoeyen, Els, Johnston, Ian C.D.
フォーマット: Artigo
言語:Inglês
出版事項: Mary Ann Liebert, Inc., publishers 2019
主題:
Research Articles
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6919281/
https://ncbi.nlm.nih.gov/pubmed/31578886
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/hum.2019.157
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料